India’s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review

Singh, Kapil; Verma, Ashwani; Narayanan, Monisha

doi:10.24171/j.phrp.2022.0104

Cited by 14 publications

(15 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The timely and speedy vaccination drive not only contained the pandemic but was instrumental in bringing normality back in nation, as also suggested by. 21 Now we are standing at the phase where COVID-19 is slowly becoming past. The world is getting normal, maskfree and moving back to development race.…”

Section: Discussionmentioning

confidence: 99%

Symptomatic prevalence of covid-19 in vaccinated and non-vaccinated population

Pandya,

Shethia,

Bangera

et al. 2023

IJMMTD

View full text Add to dashboard Cite

Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. The world has witnessed havoc with the rapid emergence of COVID-19. The unpreparedness towards the pandemic caused the whole world to face severe consequences. Emerging economies like India with a population of more than 1.3 billion faced heavy toll of life due to the rapid spread of highly contagious COVID-19 and shortage of medical supplies and infrastructure. The testing, tracing, and isolation of COVID-19 positive patients helped greatly to break the chain of COVID-19 infection, this later boosted by the vaccine production and administration on a war scale by Government of India.In this study, we have tried to understand the symptomatic effects of COVID-19 on Indian population, its prevalence, and significance. Many individuals developed symptoms like COVID-19 but tested negative for the same and vice versa. The cases of individuals not developing symptoms of COVID-19 but infected by COVID-19 act as a carrier of the virus possibly infecting other individuals unknowingly. These individuals may have weaker immunity and more submissive health conditions due to age, under surgical treatment or are infected by other chronic or acute diseases. This makes it essential to correlate and study the symptomatic incidence of COVID-19 with respect to age and vaccination status of Indian population. This study was undertaken to determine the symptomatic prevalence of COVID-19 in vaccinated and non-vaccinated patients that were tested in our laboratory. There were 86,761 samples tested out of which 49,371 samples were positives and 37,390 were negative. The samples from different parts of India were tested between1st July 2020 and 14th November 2022, dividing the total period in 5 phases for better correlation as vaccine administration started during early 2021 primarily for health workers and till it reached common people by mid of July 2021. The observations and statistical study have described the significance of vaccination and have given better insights about the working class of individuals between 18 and 45 years of age which were more exposed to infection. The study also identifies various parameters which aggravated and conciliated the symptoms of COVID-19. The study helps us to identify the prevalence and incidence of COVID-19 virus in Indian Population and can be beneficial in devising a better strategies in future to tackle symptomatic adversaries of any infection.

show abstract

Section: Discussionmentioning

confidence: 99%

Symptomatic prevalence of covid-19 in vaccinated and non-vaccinated population

Pandya,

Shethia,

Bangera

et al. 2023

IJMMTD

View full text Add to dashboard Cite

show abstract

“…The second dose of COVID-19 vaccination started on February 13, 2021 for those recipients who have completed 28 days after getting their 1st dose. Pre-registration facility was provided on Cowin 2.0, and the Arogya Setu app, also on spot registration facility was provided for the beneficiaries [ 74 ] ( https://www.aarogyasetu.gov.in/ ). As per Co-Win (Winning over COVID-19) website data, in India so far, among all vaccines available; the most widely used vaccine is Covishield followed by Covaxin and then Corbevax, with very few dose administration of another available vaccine such as Sputnik V and Covovax ( https://dashboard.cowin.gov.in/ ).…”

Section: Indian Government Drive In the Development Of Covid-19 Vaccinementioning

confidence: 99%

Section: Indian Government Drive In the Development Of Covid-19 Vaccinementioning

confidence: 99%

An assessment of the strategy and status of COVID-19 vaccination in India

et al. 2023

View full text Add to dashboard Cite

The COVID-19 disease continues to cause devastation for almost 3 years of its identification. India is one of the leading countries to set clinical trials, production, and administration of COVID-19 vaccination. Recent COVID-19 vaccine tracker record suggests that 12 vaccines are approved in India, including protein subunit, RNA/DNA, non-replicating viral vector, and inactivated vaccine. Along with that 16 more vaccines are undergoing clinical trials to counter COVID-19. The availability of different vaccines gives alternate and broad perspectives to fight against viral immune resistance and, thus, viruses escaping the immune system by mutations. Using the recently published literature on the Indian vaccine and clinical trial sites, we have reviewed the development, clinical evaluation, and registration of vaccines trial used in India against COVID-19. Moreover, we have also summarized the status of all approved vaccines in India, their associated registered clinical trials, manufacturing, efficacy, and their related safety and immunogenicity profile.

show abstract

“…The Ministry of Health and Family Welfare (MoHFW) in India responded to the pandemic with a robust pandemic control and mitigation plan of unprecedented scale. Along with other pandemic control measures, India initiated the COVID-19 vaccination drive within a year of the pandemic and successfully carried out one of the world’s largest COVID-19 vaccination drives [ 13 ]. This was a testament to India’s commitment to universal health coverage alongside the resumption of a routine immunization program.…”

Section: Introductionmentioning

confidence: 99%

Balancing Routine and Pandemic: The Synergy of India’s Universal Immunization Program and COVID-19 Vaccination Program

Kumar,

Chakraborty,

Dhandore

et al. 2023

Vaccines

Self Cite

View full text Add to dashboard Cite

The COVID-19 pandemic posed substantial challenges to healthcare systems globally and severely disrupted essential health services, including routine immunization programs. In India, these disruptions were exacerbated due to the sudden emergence of the pandemic and lockdown measures, leading to mass migrations and a shortage of healthcare workers. Caregivers’ concerns about routine immunization sessions further compounded the problem, resulting in a sharp increase in zero-dose children. This review paper examines India’s strategies for conducting one of the world’s largest COVID-19 vaccination programs while effectively restoring and perpetuating its Universal Immunization Program (UIP). The UIP played a pivotal role in sustaining immunization services during the pandemic, ultimately improving immunization coverage compared to pre-pandemic levels. India’s accomplishments in this regard are highlighted through key performance indicators, the reach of immunization services, a reduction in zero-dose children, and antigen-wise coverage. The paper also discusses the successful integration of COVID-19 vaccination within the UIP framework, underscoring the significance of existing infrastructure, technology, and capacity building. India’s dedication to concurrently managing routine immunization and COVID-19 vaccination showcases the adaptability and resilience of its healthcare system. India’s journey serves as a global example of efficient mass immunization during challenging times, emphasizing the importance of political will, healthcare infrastructure investment, skilled healthcare workforces, and comprehensive vaccination programs. In a world grappling with the dual challenge of COVID-19 and routine immunization, India’s experience provides a roadmap for strengthening healthcare systems and promoting public health as the critical agenda in challenging times.

show abstract

India’s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review

Cited by 14 publications

References 13 publications

Symptomatic prevalence of covid-19 in vaccinated and non-vaccinated population

Symptomatic prevalence of covid-19 in vaccinated and non-vaccinated population

An assessment of the strategy and status of COVID-19 vaccination in India

Balancing Routine and Pandemic: The Synergy of India’s Universal Immunization Program and COVID-19 Vaccination Program

Contact Info

Product

Resources

About